The impact of indacaterol/glycopyrronium fixed-dose combination versus tiotropium monotherapy on lung function and treatment preference: a randomized crossover study – the FAVOR study

Peter Kardos,1 Ina Hagedorn-Peinz2 1Pulmonary Department, Respiratory and Sleep Medicine at Red Cross Maingau Hospital, Group Practice Allergy, Frankfurt, Germany; 2Novartis Pharma GmbH, Nuremberg, Germany Background: The objective of the FAVOR study was to evaluate the effect of indacaterol/glyco...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Kardos P, Hagedorn-Peinz I
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Dove Medical Press 2017-12-01
Saila:	International Journal of COPD
Gaiak:	COPD dual-bronchodilators FEV1 indacaterol/glycopyrronium treatment preference treatment satisfaction
Sarrera elektronikoa:	https://www.dovepress.com/the-impact-of-indacaterolglycopyrronium-fixed-dose-combination-versus--peer-reviewed-article-COPD
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!